January 29, 2015 5:36 PM ET


Company Overview of Inhibitex, Inc.

Company Overview

Inhibitex, Inc., a biopharmaceutical company, focuses on the development of differentiated anti-infective products to prevent or treat serious infections. It primarily focuses to treat shingles caused by the varicella zoster virus and chronic infections caused by hepatitis C virus (HCV). Its antiviral product candidates include INX-189, a HCV nucleoside polymerase inhibitor that has completed Phase Ib clinical trials for the treatment of chronic hepatitis C infection; FV-100, an orally available nucleoside analogue prodrug, which is in Phase II clinical trials for the treatment of herpes zoster or shingles. The company is also developing anti-bacterials comprising Staphylococcal Vaccines, wh...

9005 Westside Parkway

Alpharetta, GA 30009

United States

Founded in 1994

33 Employees





Key Executives for Inhibitex, Inc.

Chief Executive Officer
Age: 55
President and Director
Age: 50
Senior Vice President of Drug Development
Age: 66
Chief Medical Officer and Vice President of Clinical Development
Age: 62
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Native Traits Corp United States
Ultra Voice United States
Grand River Technologies, Inc. United States
Crystalplex Corp. United States
MyGene International Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inhibitex, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.